When Jared Adkins opened Bluebird Distilling in 2014, he spent $1 million to renovate a dilapidated warehouse with his father, a retired contractor. A decade later, he's now spending twice as much ...

Bluebird is partnering with Teamwork Commerce to launch a next-generation RFID integration that transforms how retailers manage inventory. The integration pairs Bluebird’s high-performance RFR901 RFID ...

Bluebird Bio, Inc. (NASDAQ:BLUE) shares are trading higher on Wednesday following the news that Bluebird Bio, Carlyle, and SK Capital Partners, LP, have amended their definitive agreement.

Under the terms of the amended agreement, Bluebird stockholders can elect to receive either the original offer of $3.00 per share in cash plus a contingent value right (CVR) of $6.84 per share in ...

May 14 (Reuters) - Carlyle Group (CG.O), opens new tab and SK Capital Partners increased their upfront offer to take over gene therapy maker bluebird bio (BLUE.O), opens new tab, the companies ...

Bluebird bio shareholders have dragged their feet in tendering shares as part of the company’s sale process, prompting buyers Carlyle and SK Capital to extend their offer deadline once again.

Blue Bird, the iconic American school bus manufacturer and one of the largest electric school bus makers, has announced an all-electric medium duty Class 5-6 truck chassis. You may know Blue Bird ...

Ayrmid submits an unsolicited takeover offer for Bluebird Bio. Bluebird Bio's board is currently reviewing the new offer with legal and financial advisors. Ready to turn the market’s comeback ...

Bluebird Bio has received a competing bid from Ayrmid to buy the cash-strapped gene-therapy company in a deal potentially valued at up to $110.5 million. Bluebird said late Friday that Ayrmid made ...

SOMERVILLE, Mass.--(BUSINESS WIRE)-- bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird”) today confirmed it has received an unsolicited non-binding written proposal ...

A Bluebird Bio researcher at work. Bluebird has entered into a definitive agreement to be acquired by funds managed by Carlyle and SK Capital Partners, partnering with a team of veteran biotech ...

Bluebird Bio, a company that steered three gene therapies to FDA approval but struggled to commercialize them, has found the cash it needs to put those therapies on stronger financial footing by ...